Feixiong Cheng, Ph.D.

Dr. Cheng is a computational and systems pharmacologist by training, with expertise in analyzing, visualizing, and mining data from real world (e.g., electronic health records and health care claims) and experiments that profile the molecular state of human cells and tissues by genomics, transcriptomics, proteomics, metabolomics, and interactomics (protein-protein interactions), for drug discovery and patient care. The primary goal of Cheng lab is to combine tools from genomics, network medicine, artificial intelligence, and experimental systems pharmacology assays, to identify novel real-world data-driven diagnostic biomarkers and therapeutic targets for precision medicine drug discovery (including Alzheimer’s disease, Cardio-Oncology, and COVID-19).



Electronic Health Records Breakout Session I